JPMorgan Chase & Co’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-63,491
| Closed | -$7K | – | 5099 |
|
|
2018
Q4 | $7K | Sell |
63,491
-1,810,106
| -97% | -$200K | ﹤0.01% | 4678 |
|
|
2018
Q3 | $3.19M | Buy |
1,873,597
+93,320
| +5% | +$159K | ﹤0.01% | 2517 |
|
|
2018
Q2 | $3.1M | Sell |
1,780,277
-45,989
| -3% | -$80K | ﹤0.01% | 2549 |
|
|
2018
Q1 | $3.34M | Sell |
1,826,266
-937,272
| -34% | -$1.72M | ﹤0.01% | 2462 |
|
|
2017
Q4 | $6.16M | Sell |
2,763,538
-641,839
| -19% | -$1.43M | ﹤0.01% | 2113 |
|
|
2017
Q3 | $8.82M | Buy |
3,405,377
+1,417,177
| +71% | +$3.67M | ﹤0.01% | 1817 |
|
|
2017
Q2 | $8.85M | Buy |
1,988,200
+752,475
| +61% | +$3.35M | ﹤0.01% | 1787 |
|
|
2017
Q1 | $5.76M | Sell |
1,235,725
-42,050
| -3% | -$196K | ﹤0.01% | 2019 |
|
|
2016
Q4 | $7.78M | Sell |
1,277,775
-23,169
| -2% | -$141K | ﹤0.01% | 1837 |
|
|
2016
Q3 | $7.17M | Buy |
1,300,944
+62,748
| +5% | +$346K | ﹤0.01% | 1782 |
|
|
2016
Q2 | $4.71M | Sell |
1,238,196
-65,890
| -5% | -$250K | ﹤0.01% | 2058 |
|
|
2016
Q1 | $3.6M | Buy |
1,304,086
+281,991
| +28% | +$778K | ﹤0.01% | 2116 |
|
|
2015
Q4 | $5.8M | Sell |
1,022,095
-133,225
| -12% | -$755K | ﹤0.01% | 1869 |
|
|
2015
Q3 | $6.12M | Buy |
1,155,320
+830,625
| +256% | +$4.4M | ﹤0.01% | 1853 |
|
|
2015
Q2 | $2.7M | Buy |
+324,695
| New | +$2.7M | ﹤0.01% | 2376 |
|
|
2014
Q4 | – | Sell |
-103,399
| Closed | -$287K | – | 3564 |
|
|
2014
Q3 | $287K | Sell |
103,399
-3,779
| -4% | -$10.5K | ﹤0.01% | 3174 |
|
|
2014
Q2 | $436K | Buy |
107,178
+59,152
| +123% | +$241K | ﹤0.01% | 3086 |
|
|
2014
Q1 | $255K | Buy |
+48,026
| New | +$255K | ﹤0.01% | 3271 |
|
|
2013
Q4 | – | Sell |
-21,926
| Closed | -$98K | – | 3862 |
|
|
2013
Q3 | $98K | Sell |
21,926
-16,103
| -42% | -$72K | ﹤0.01% | 3771 |
|
|
2013
Q2 | $162K | Buy |
+38,029
| New | +$162K | ﹤0.01% | 3593 |
|